Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	46
Overall Study	STARTED	Etoricoxib 90 mg	191
Overall Study	STARTED	Etoricoxib 120 mg	97
Overall Study	STARTED	Ibuprofen 2400 mg	192
Overall Study	STARTED	Acetaminophen 2400 mg/Codeine 240 mg	62
Overall Study	COMPLETED	Placebo	45
Overall Study	COMPLETED	Etoricoxib 90 mg	188
Overall Study	COMPLETED	Etoricoxib 120 mg	95
Overall Study	COMPLETED	Ibuprofen 2400 mg	189
Overall Study	COMPLETED	Acetaminophen 2400 mg/Codeine 240 mg	56
Overall Study	NOT COMPLETED	Placebo	1
Overall Study	NOT COMPLETED	Etoricoxib 90 mg	3
Overall Study	NOT COMPLETED	Etoricoxib 120 mg	2
Overall Study	NOT COMPLETED	Ibuprofen 2400 mg	3
Overall Study	NOT COMPLETED	Acetaminophen 2400 mg/Codeine 240 mg	6

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00694369/flow